Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements-Reference-Cited by-同舟云学术

Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements

Published:2018-10 Issue:10 Volume:14 Page:951-963
ISSN:1551-7411
Container-title:Research in Social and Administrative Pharmacy
language:en
Short-container-title:Research in Social and Administrative Pharmacy

Author:

Betts Kevin R.,Boudewyns Vanessa,Aikin Kathryn J.^ORCID,Squire Claudia,Dolina Suzanne,Hayes Jennifer J.^ORCID,Southwell Brian G.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacy

Reference57 articles.

1. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising;Frosch;Ann Fam Med,2007

2. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising;Frosch;Am J Public Health,2010

3. Consumer attitudes and behaviors associated with direct-to-consumer prescription drug marketing;Friedman;J Consum Mark,2007

4. Patient and Physician Attitudes and Behaviors Associated with DTCA Promotion of Prescription Drugs—summary of FDA Survey Research Results;Aikin,2004

5. Do prescription drug ads tell consumers enough about benefits and side effects? Results from the Health Information National Trends Survey, fourth administration;Sullivan;J Health Commun,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease Awareness and Prescription Drug Communications on Television: Evidence for Conflation and Misleading Product Impressions;Health Communication;2024-03-13

2. A scoping review of empirical research on prescription drug promotion;Research in Social and Administrative Pharmacy;2023-06

3. Patient Understanding of Oncology Clinical Trial Endpoints in Direct-to-Consumer Television Advertising;The Oncologist;2023-04-20

4. Implied Claims in Drug Advertising: A Review of Recent Literature and Regulatory Actions;Health Communication;2023-02-24

5. Attention to risk information in direct‐to‐consumer prescription drug print ads: An eye‐tracking study;Pharmacoepidemiology and Drug Safety;2022-07-31